Original ContributionPulmonary Dysfunction as a Major Cause of Inoperability Among Patients with Non–Small-Cell Lung Cancer
References (31)
- et al.
Preoperative evaluation of patients undergoing lung resection surgery
Chest
(2003) - et al.
Lung cancer surgery–preoperative risk assessment and patient selection
Lung Cancer
(2001) - et al.
Patient and hospital characteristics related to in-hospital mortality after lung cancer resection
Chest
(1992) - et al.
Use of Medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer
Chest
(1991) - et al.
Exercise testing in the evaluation of patients at high risk for complications from lung resection
Chest
(1992) - et al.
American College of Chest Physicians. The physiologic evaluation of patients with lung cancer being considered for resectional surgery
Chest
(2003) - et al.
Preoperative risk assessment for marginal patients requiring pulmonary resection
Ann Thorac Surg
(2003) Revisions in the International System for Staging Lung Cancer
Chest
(1997)- et al.
Regional and overall pulmonary function changes in lung cancer. Correlations with tumor stage, extent of pulmonary resection, and patient survival
J Thorac Cardiovasc Surg
(1983) - et al.
Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma
Chest
(1980)
Observation-only management of early stage, medically inoperable lung cancer: poor outcome
Chest
The effect of surgical treatment on survival from early lung cancer. Implications for screening
Chest
Impact of limited pulmonary function on the management of resectable lung cancer
Lung Cancer
The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea
Chest
Recommendations for the management of COPD
Chest
Cited by (34)
“Fit for Surgery? What's New in Preoperative Assessment of the High-Risk Patient Undergoing Pulmonary Resection”
2021, Journal of Cardiothoracic and Vascular AnesthesiaCitation Excerpt :However, uncertainty exists regarding the upper age limit for screening, and the risk-benefit in those with significant comorbidity and functional limitation.5 Up to 40% of patients with anatomically resectable lung cancer may be considered inoperable on the basis of severe pulmonary dysfunction alone.6 Parenchymal- sparing surgery, minimally invasive thoracoscopic surgery, and improvements in perioperative management have increased the pool of high-risk cases that may be amenable to surgical management.7
CT Densitometry and Morphology of Radiofrequency-Ablated Stage IA Non–Small Cell Lung Cancer: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) Trial
2020, Journal of Vascular and Interventional RadiologyCitation Excerpt :Key among them is preservation of lung function and, thus, functional state, especially in patients with emphysema and low pulmonary reserve (3,7). A single-institution retrospective study discovered that 37% of patients with anatomically resectable tumors were deemed nonsurgical candidates secondary to poor lung function (20). Many patients with lung cancer have concomitant pulmonary disease and dysfunction, thus an alternative treatment modality for nonsurgical patients that preserves functioning parenchyma is critical.
Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer
2019, Abeloff’s Clinical OncologyCancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer
2013, Abeloff's Clinical Oncology: Fifth EditionWhen Should Pulmonary Function Tests Be Performed Preoperatively?
2013, Evidence-Based Practice of Anesthesiology
Electronic forwarding or copying is a violation of US and International Copyright Laws.
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by CIG Media Group, LP, ISSN #1525-7304, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.